Blog
RSS FeedPosted by Michael Wonder on 16 Jan 2017
‘Precision medicine’ promises new hope for cancer sufferers
17 January 2017 - A shift from mass to personalised medicine promises new hope for cancer sufferers and health authorities, ...
Posted by Michael Wonder on 16 Jan 2017
Health insurance premiums set to rise
16 January 2017 - Australian families could soon be forking out an extra $200 for private health cover as insurers ...
Posted by Michael Wonder on 14 Jan 2017
Private health insurance nears crisis point as costs soar
14 January 2017 - Health insurance chiefs have warned that the issue of affordability is close to crisis point as ...
Posted by Michael Wonder on 13 Jan 2017
Pharmacists get power to alter prescriptions under controversial trial
11 January 2017 - Pharmacists will have the power to alter prescriptions for patients with chronic conditions like asthma in ...
Posted by Michael Wonder on 12 Jan 2017
Additional listings on the Pharmaceutical Schedule of a range of orthopaedic joint implants, additional CMF implants, associated products and bone cement with Stryker
12 January 2017 - PHARMAC is pleased to announce the approval of an amendment to the trauma, spine and CMF ...
Posted by Michael Wonder on 12 Jan 2017
NICE approves kidney cancer drug for NHS use
12 January 2017 - Patients with advanced kidney cancer will have routine NHS access to the drug everolimus following recommendations by ...
Posted by Michael Wonder on 12 Jan 2017
Aussie pharmaceuticals whacked by Donald Trump
12 January 2017 - Australian health stocks took an early hit on the local market following US president elect Donald ...
Posted by Michael Wonder on 11 Jan 2017
NICE publishes final guidance on the use of Keytruda for non-small-cell lung cancer
11 January 2017 - The guidance relates to the use of Keytruda (pembrolizumab) for treating PD-L1-positive non-small-cell lung cancer in adults ...
Posted by Michael Wonder on 10 Jan 2017
AbbVie withdraws submission for Venclexta
10 January 2017 - Abbvie was seeking funding for venetoclax when used as a treatment for patients with chronic lymphocytic ...
Posted by Michael Wonder on 10 Jan 2017
The real health-care change we need? Strong leadership
10 January 2017 - Saskatchewan has announced that it will scrap its 12 health regions and create a single health ...
Posted by Michael Wonder on 09 Jan 2017
Cost of older Australians with diabetes to hit $2.9 billion by 2030, new research shows
10 January 2017 - The indirect economic cost of rising numbers of ageing Australians with diabetes, measured in 'lost productive ...
Posted by Michael Wonder on 09 Jan 2017
NICE takes key role in new European project for faster access to Alzheimer’s disease drugs
6 January 2017 - Patients’ priorities will be brought to the fore in new Alzheimer’s project. ...
Posted by Michael Wonder on 09 Jan 2017
Health insurers offer parents a rebate for Bexsero meningococcal B vaccine which is not on the PBS
8 January 2017 - Parents wanting to vaccinate their children against meningococcal B should check if they are eligible for ...
Posted by Michael Wonder on 09 Jan 2017
Seeking thought leaders: new advisory council to Medicines Australia
9 January 2017 - The future focussed Advisory Council will provide the Board with strategic advice on trends and issues ...
Posted by Michael Wonder on 08 Jan 2017
Taste of their own medicine
4 January 2017 - The Pharmacy Guild of Australia is the most disciplined and cashed-up lobby group in the country. ...